What is the Shield blood test?
The Shield blood test is a convenient, FDA-approved blood test for colorectal cancer screening for adults 45 and older.
Yanuki
ARTICLE DETAIL
James Van Der Beek Teams Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+ | Femtech Market Growth to $26 Billion by 2033: Key Insights and Opportunities | Preparing for Daylight Saving Time 2026: What You Need to Know | Oscar-Nominated Directors Highlight Workers at a Women's Health Clinic in 'The Devil Is Busy' | Trump Spotted with Rash on Neck: Possible Causes and Theories | Olympic Village Condom Shortage: A Hot Topic at the 2026 Winter Games | Talcum Powder and Cancer: Unveiling the Connection | Drug-Resistant Typhoid Fever: An Ancient Killer Returns | RFK Jr.'s CDC Panel to Discuss Covid Vaccine Injuries | James Van Der Beek Teams Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+ | Femtech Market Growth to $26 Billion by 2033: Key Insights and Opportunities | Preparing for Daylight Saving Time 2026: What You Need to Know | Oscar-Nominated Directors Highlight Workers at a Women's Health Clinic in 'The Devil Is Busy' | Trump Spotted with Rash on Neck: Possible Causes and Theories | Olympic Village Condom Shortage: A Hot Topic at the 2026 Winter Games | Talcum Powder and Cancer: Unveiling the Connection | Drug-Resistant Typhoid Fever: An Ancient Killer Returns | RFK Jr.'s CDC Panel to Discuss Covid Vaccine Injuries
Health / Cancer
James Van Der Beek Teams Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
Actor James Van Der Beek, known for his roles in *Varsity Blues* and *Rules of Attraction*, is partnering with Guardant Health to raise awareness about colorectal cancer (CRC) screening, especially the Shield™ blood test, a convenient new o...
Key Insights
- James Van Der Beek, who was diagnosed with stage 3 colorectal cancer, is advocating for early screening.
- The Shield blood test, approved by the FDA, offers a more convenient screening option.
- CRC is the second most deadly cancer in the U.S., but early detection significantly increases survival rates.
- More than 50 million Americans avoid CRC screening due to inconvenient traditional methods.
- The National Comprehensive Cancer Network included the Shield blood test in its updated CRC screening guidelines.
In-Depth Analysis
Colorectal cancer (CRC) is a significant health concern in the United States. Over 50,000 Americans die from the disease each year, making it the second most deadly cancer in the U.S. However, when detected early, the five-year survival rate is over 90%. Unfortunately, more than 50 million adults aged 45 and over avoid screening, partly due to the unpleasantness and inconvenience of traditional methods.
Guardant Health’s Shield blood test offers a convenient alternative. Approved by the FDA, Shield allows individuals to undergo screening with a simple blood draw, with results available within two weeks. The National Comprehensive Cancer Network has included the Shield blood test in its updated CRC screening guidelines, potentially improving patient access.
James Van Der Beek’s personal experience with CRC has motivated him to advocate for screening. He emphasizes the importance of staying up to date with CRC screening guidelines and encourages others to discuss screening options with their doctors.
The partnership between Van Der Beek and Guardant Health aims to increase awareness and promote the Shield blood test as a convenient and effective screening option. By addressing the barriers to traditional screening methods, this initiative hopes to improve early detection rates and ultimately save lives.
FAQ
Why is early detection of colorectal cancer important?
Early detection significantly increases the chances of successful treatment and survival. The five-year survival rate is over 90% when CRC is caught in its early stages.
Who is James Van Der Beek?
James Van Der Beek is an actor and health advocate known for his roles in *Varsity Blues* and *Rules of Attraction*. He is partnering with Guardant Health to raise awareness about colorectal cancer screening after being diagnosed with stage 3 CRC.
Where can I find more information about the Shield blood test?
For more information, visit [www.ShieldCancerScreen.com?ref=yanuki.com](www.ShieldCancerScreen.com?ref=yanuki.com).
Takeaways
- Colorectal cancer is a serious health concern, but early detection can save lives.
- The Shield blood test offers a convenient alternative to traditional screening methods.
- If you are 45 or older, talk to your doctor about CRC screening guidelines and options.
- James Van Der Beek is advocating for increased awareness and early screening following his own CRC diagnosis.
Discussion
Do you think convenient screening options like the Shield blood test will increase early detection rates for colorectal cancer? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Sources
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.